PTC Therapeutics will be hosting an Informational Patient Webinar on July 28th at 7pm for those interested in learning more about PTC-743, a candidate molecule for the treatment of Friedreich's ataxia. The clinical trial for PTC-743 will be international and include clinic sites in Australia, Brazil, Canada, the E.U., and the U.S.

Please email This email address is being protected from spambots. You need JavaScript enabled to view it. if you are interested in attending this Webinar.